Fortrea
Sivan Frank serves as the Senior Director of Business Development and Sales at Fortrea, a Clinical Research Organization that emerged from Labcorp, since July 2023. Prior to this role, Sivan held the position of Senior Director of Business Development and Sales at Labcorp Drug Development from January 2022 to July 2023. Sivan's experience also includes working as a Senior Clinical Project Manager at PRA Health Sciences from July 2020 until its acquisition by ICON in February 2021. A notable sabbatical occurred from July 2019 to June 2020, during which Sivan settled back in Israel following relocation and the COVID-19 pandemic. Previous positions include Head of Clinical Study Start-Up Operations for Germany, Austria, and Switzerland at Labcorp Drug Development and Clinical Operations Manager at Covance. Sivan has a strong educational background, with multiple degrees including an MBA from Technion - Israel Institute of Technology and a Master of Biomedical Sciences from The Hebrew University of Jerusalem.
This person is not in any offices
Fortrea
13 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.